Back

Mapping the Middle East Respiratory Syndrome (MERS) related Research - A Scoping Review (2012-2023)

Hassan, M. A.; Yarow, H.; Mccabe, R.; Dobschuetz, S. V.; Khan, W.; Barakat, A.; Kerkhove, M. D. V.; Abu Bakar, A.; Abou El Naja, H.

2023-11-08 infectious diseases
10.1101/2023.11.08.23298197 medRxiv
Show abstract

BackgroundMiddle East respiratory syndrome (MERS), is a zoonotic disease caused by MERS coronavirus (MERS-CoV). The purpose of this scoping review was to take stock of the empirical research evidence for MERSDCoV, map the information to priority research areas as set out in existing MERS-CoV research roadmaps, identify technical areas that received less attention and set recommendations for the advancement of MERS-CoV research. MethodsWe undertook a scoping review for MERS-CoV, comprehensively searching the three databases PubMed, EMBASE, and CINAHL for studies published between 1 January 2012 and 24 January 2023. Two reviewers screened studies and extracted data using a pilot-tested screening form. We categorized studies into priority research areas outlined in existing roadmaps and summarized the evidence available for each category. ResultsA total of 1,264 records were included in the review, assigned into pre-defined categories. 33% of the included records were molecular genetics studies, followed by therapeutic studies (17.6%) and pathogenesis studies (15.6%). We found that, while there has been a substantial research effort on MERS-CoV, many technical themes pertaining to the areas of animal, human, animal-human interface, and environmental research identified by FAO, WHO, and WOAH in the past have not sufficiently been addressed to date. This includes asymptomatic human cases role in transmission, human exposure risk from dromedary products, reinfection, analyses of camel value chain and production systems, and anthropological studies characterizing interactions at the animal-human interface, in addition to studies highlighting the role of environmental factors in MERS-CoV transmission. ConclusionOur study highlights the continued need for coordinated action to better prepare for, prevent, detect, and respond to MERS-CoV. Examples include the need for enhancing collaborative surveillance, accelerating the development of MERS-CoV medical countermeasures, strengthening community protection, reducing MERS-CoV transmission at healthcare facility level and reinforcing multi-sectoral coordination using the One Health approach.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
One Health
29 papers in training set
Top 0.1%
33.4%
2
PLOS ONE
4510 papers in training set
Top 13%
14.5%
3
Emerging Infectious Diseases
103 papers in training set
Top 0.2%
6.4%
50% of probability mass above
4
PLOS Neglected Tropical Diseases
378 papers in training set
Top 2%
3.1%
5
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 1%
2.8%
6
Eurosurveillance
80 papers in training set
Top 0.5%
2.1%
7
International Journal of Environmental Research and Public Health
124 papers in training set
Top 4%
1.7%
8
Environmental Research
46 papers in training set
Top 0.8%
1.7%
9
Transboundary and Emerging Diseases
34 papers in training set
Top 0.4%
1.5%
10
Journal of Hospital Infection
27 papers in training set
Top 0.4%
1.2%
11
Epidemiology and Infection
84 papers in training set
Top 2%
1.2%
12
Epidemics
104 papers in training set
Top 1%
1.2%
13
Clinical Infectious Diseases
231 papers in training set
Top 4%
1.1%
14
Scientific Reports
3102 papers in training set
Top 68%
1.1%
15
Travel Medicine and Infectious Disease
15 papers in training set
Top 0.5%
0.9%
16
Open Forum Infectious Diseases
134 papers in training set
Top 2%
0.9%
17
Science of The Total Environment
179 papers in training set
Top 4%
0.9%
18
Clinical Microbiology and Infection
60 papers in training set
Top 1%
0.8%
19
BMC Infectious Diseases
118 papers in training set
Top 5%
0.8%
20
Frontiers in Public Health
140 papers in training set
Top 8%
0.8%
21
Tropical Medicine and Infectious Disease
12 papers in training set
Top 0.6%
0.7%
22
BMC Public Health
147 papers in training set
Top 6%
0.7%
23
PLOS Global Public Health
293 papers in training set
Top 6%
0.7%
24
Viruses
318 papers in training set
Top 6%
0.7%
25
The Lancet Microbe
43 papers in training set
Top 2%
0.5%
26
International Journal of Infectious Diseases
126 papers in training set
Top 4%
0.5%
27
Pathogens
53 papers in training set
Top 2%
0.5%
28
Systematic Reviews
11 papers in training set
Top 0.8%
0.5%